Skip to main content
. 2012 Jun 7;18(21):2661–2667. doi: 10.3748/wjg.v18.i21.2661

Table 2.

Distribution of patients with positive family history by age and tumor staging n (%)

n Age (yr, median) Range P value
Family members
Father 29 53 29.0-78.0 0.101
Mother 42 48.5 33.0-79.0
Siblings 102 39 30.0-48.0
HBV infection HBV (+) (n = 136) HBV (-) (n = 29)
Age Median (min-max) 52.0 (30.0-78.0) 57.0 (29.0-79.0) 0.065
< 20 0 (0.0) 0 (0.0) 0.001
20-29 0 (0.0) 1 (3.4)
30-39 12 (8.8) 1 (3.4)
40-49 39 (28.7) 9 (31.0)
50-59 56 (41.2) 5 (17.5)
60-69 26 (19.1) 8 (27.6)
70-79 3 (2.2) 5 (17.2)
≥ 80 0 (0.0) 0 (0.0)
Stage 1 17 (12.5) 1 (3.4) 0.056
2 46 (33.8) 8 (27.6)
3 26 (19.1) 12 (41.4)
4 47 (33.6) 8 (27.6)
HCV infection HCV (+) (n = 18) HCV (-) (n = 147)
Age Median (min-max) 54.0 (29.0-75.0) 52.0 (30.0-79.0) 0.629
< 20 0 (0.0) 0 (0.0) 0.026
20-29 1 (5.9) 0 (0.0)
30-39 1 (5.9) 12 (8.1)
40-49 5 (29.4) 43 (29.1)
50-59 3 (17.6) 58 (39.2)
60-69 6 (35.3) 28 (18.9)
70-79 1 (5.9) 7 (4.7)
≥ 80 0 (0.0) 0 (0.0)
Stage 1 18 (12.2) 0 (0.0) 0.335
2 49 (33.1) 5 (29.4)
3 32 (21.6) 6 (35.3)
4 49 (33.1) 6 (35.3)

HBV: Hepatitis B virus; HCV: Hepatitis C virus; FHx: Family history.